96 results
8-K/A
EX-10.1
NEO
Neogenomics Inc.
18 Jul 22
Departure of Directors or Certain Officers
4:31pm
beyond normal retirement, under the Equality Act 2010 or the Employment Equality (Age) Regulations 2006;
(x)for direct or indirect discrimination
8-K
o448fjk 3vtm
11 May 22
NeoGenomics Announces Leadership Transition Appointing Vishal Sikri as President and Chief Commercial Officer of Inivata Liquid Biopsy Subsidiary
5:02pm
8-K
EX-99.1
2ra1hk05zf3ta wonw
14 Apr 22
Other Events
4:23pm
8-K
EX-10.1
17am7eej
28 Mar 22
NeoGenomics Announces CEO Departure and Initiates CEO Search
4:20pm
8-K
EX-99.1
xd3vn8eq654ulazh2fk8
23 Feb 22
NeoGenomics Reports Full Year Revenue of $484 Million and Fourth Quarter Results
7:14am
8-K
EX-99.1
7tno6y47np2nnmxobqx
4 Nov 21
NeoGenomics Reports Revenue of $121 Million
7:23am
8-K
EX-99.1
pu4e2m78rr6f0x
12 Oct 21
NeoGenomics Announces Board of Directors’ Transition
5:03pm
8-K
s3sy6izr6cb4d 1fw5zf
12 Oct 21
NeoGenomics Announces Board of Directors’ Transition
5:03pm
8-K
EX-99.1
dneetjan26g49 gz21mz
10 Aug 21
Regulation FD Disclosure
5:09pm
8-K
EX-99.1
2jrh5lmy ywwjj
6 Aug 21
NeoGenomics Reports 40% Revenue Growth to $122 Million
7:10am